Arch Therapeutics, Inc.

SEC insider activity covers quarterly filings through June 30, 2026. Later filings are not included. Reported roles do not establish current employment or current holdings. SEC filing documents, sections and filing-text search cover filings dated January 1, 2000 onward. Earlier filings are deferred until after launch.

organization

SEC Insider

$37.19B

88 transactions

Summary

Arch Therapeutics, Inc. is an organization.

Recent Insider Transactions

As filed, including amendments; not net cash flow or current holdings. Joint reports count once. Totals cover known values only.

Buys: $8KSales: —12 insiders

Date	Insider	Type	Value
2022-07-06	Norchi Terrence W(PRESIDENT AND CHIEF EXECUTIVE)	A	$24K
2023-08-31	Hicks Laurence	Buy	$3K
2023-08-31	ABRAMS MICHAEL S(CHIEF FINANCIAL OFFICER)	Buy	$3K
2023-08-31	Norchi Terrence W(PRESIDENT AND CHIEF EXECUTIVE)	Buy	$2K
2023-08-31	Hicks Laurence	A	—
2023-08-31	Norchi Terrence W(PRESIDENT AND CHIEF EXECUTIVE)	A	—
2023-08-31	ABRAMS MICHAEL S(CHIEF FINANCIAL OFFICER)	A	—
2022-11-10	ABRAMS MICHAEL S(CHIEF FINANCIAL OFFICER)	A	$0
2022-11-10	Norchi Terrence W(PRESIDENT AND CHIEF EXECUTIVE)	A	$0
2022-11-10	Yrigoyen Dan(VICE PRESIDENT, SALES)	A	$0
2022-11-10	Hicks Laurence	A	$0
2022-11-10	Fish Guy L.	A	$0
2022-11-10	DHILLON PUNIT	A	$0
2022-07-06	Hicks Laurence	A	—
2022-07-06	Hicks Laurence	A	—
2022-07-06	Hicks Laurence	A	—
2022-07-06	Norchi Terrence W(PRESIDENT AND CHIEF EXECUTIVE)	A	—
2022-07-06	Norchi Terrence W(PRESIDENT AND CHIEF EXECUTIVE)	A	—
2022-07-06	ABRAMS MICHAEL S(CHIEF FINANCIAL OFFICER)	A	—
2022-07-06	ABRAMS MICHAEL S(CHIEF FINANCIAL OFFICER)	A	—

SEC filings: SEC EDGAR

Activity data: SEC EDGAR

Arch Therapeutics, Inc. — Contributions, Lobbying & Contracts | Poliscope